Furue M, Ishii Y, Tsukimori K, Tsuji G. Aryl Hydrocarbon Receptor and Dioxin-Related Health Hazards-Lessons from Yusho. Int J Mol Sci. 2021 Jan 12;22(2):708. doi: 10.3390/ijms22020708. PMID: 33445793; PMCID: PMC7828254.
Furue M, Tsuji G. Chloracne and Hyperpigmentation Caused by Exposure to Hazardous Aryl Hydrocarbon Receptor Ligands. Int J Environ Res Public Health. 2019 Dec 3;16(23):4864. doi: 10.3390/ijerph16234864. PMID: 31816860; PMCID: PMC6926551.
Peng F, Tsuji G, Zhang JZ, Chen Z, Furue M. Potential role of PM2.5 in melanogenesis. Environ Int. 2019 Nov;132:105063. doi: 10.1016/j.envint.2019.105063. Epub 2019 Aug 6. PMID: 31394397.
Furue M, Fuyuno Y, Mitoma C, Uchi H, Tsuji G. Therapeutic Agents with AHR Inhibiting and NRF2 Activating Activity for Managing Chloracne. Antioxidants (Basel). 2018 Jul 13;7(7):90. doi: 10.3390/antiox7070090. PMID: 30011787; PMCID: PMC6071176.
Matsuda-Taniguchi T, Takemura M, Nakahara T, Hashimoto-Hachiya A, Takai-Yumine A, Furue M, Tsuji G. The Antidiabetic Agent Metformin Inhibits IL-23 Production in Murine Bone-Marrow-Derived Dendritic Cells. J Clin Med. 2021 Nov 29;10(23):5610. doi: 10.3390/jcm10235610. PMID: 34884312; PMCID: PMC8658299.
Miyamoto K, Dissanayake B, Omotezako T, Takemura M, Tsuji G, Furue M. Daily Fluctuation of Facial Pore Area, Roughness and Redness among Young Japanese Women; Beneficial Effects of Galactomyces Ferment Filtrate Containing Antioxidative Skin Care Formula. J Clin Med. 2021 Jun 5;10(11):2502. doi: 10.3390/jcm10112502. PMID: 34198790; PMCID: PMC8200969.
Tsuji G, Takai-Yumine A, Kato T, Furue M. Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine. Cell Death Dis. 2021 May 19;12(6):513. doi: 10.1038/s41419-021-03802-9. PMID: 34011935; PMCID: PMC8134427.
Vu YH, Hashimoto-Hachiya A, Takemura M, Yumine A, Mitamura Y, Nakahara T, Furue M, Tsuji G. IL-24 Negatively Regulates Keratinocyte Differentiation Induced by Tapinarof, an Aryl Hydrocarbon Receptor Modulator: Implication in the Treatment of Atopic Dermatitis. Int J Mol Sci. 2020 Dec 10;21(24):9412. doi: 10.3390/ijms21249412. PMID: 33321923; PMCID: PMC7764126.
Tsuji G, Hashimoto-Hachiya A, Yen VH, Miake S, Takemura M, Mitamura Y, Ito T, Murata M, Furue M, Nakahara T. Aryl Hydrocarbon Receptor Activation Downregulates IL-33 Expression in Keratinocytes via Ovo-Like 1. J Clin Med. 2020 Mar 24;9(3):891. doi: 10.3390/jcm9030891. PMID: 32214018; PMCID: PMC7141508.
Tsuji G, Hashimoto-Hachiya A, Yen VH, Takemura M, Yumine A, Furue K, Furue M, Nakahara T. Metformin inhibits IL-1β secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis. Cell Death Discov. 2020 Mar 4;6:11. doi: 10.1038/s41420-020-0245-8. PMID: 32194991; PMCID: PMC7055596.
Furue M, Hashimoto-Hachiya A, Tsuji G. Aryl Hydrocarbon Receptor in Atopic Dermatitis and Psoriasis. Int J Mol Sci. 2019 Oct 31;20(21):5424. doi: 10.3390/ijms20215424. PMID: 31683543; PMCID: PMC6862295.
Furue M, Uchi H, Mitoma C, Hashimoto-Hachiya A, Tanaka Y, Ito T, Tsuji G. Implications of tryptophan photoproduct FICZ in oxidative stress and terminal differentiation of keratinocytes. G Ital Dermatol Venereol. 2019 Feb;154(1):37-41. doi: 10.23736/S0392-0488.18.06132-1. Epub 2018 Jul 20. PMID: 30035475.
Furue M, Hashimoto-Hachiya A, Tsuji G. Antioxidative Phytochemicals Accelerate Epidermal Terminal Differentiation via the AHR-OVOL1 Pathway: Implications for Atopic Dermatitis. Acta Derm Venereol. 2018 Nov 5;98(10):918-923. doi: 10.2340/00015555-3003. PMID: 29972223.